Log in

Relevant bibliographies by topics / Comorbid condition

Academic literature on the topic 'Comorbid condition'

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Comorbid condition.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Comorbid condition"

1

Roth, Thomas. "Challenges in the comorbid condition." Sleep Medicine 8 (December 2007): S1—S2. http://dx.doi.org/10.1016/s1389-9457(08)70001-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Wright, Anne J. "Nocturnal enuresis: a comorbid condition." Jornal de Pediatria 96, no. 3 (May 2020): 276–78. http://dx.doi.org/10.1016/j.jped.2019.04.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wright, Anne J. "Nocturnal enuresis: a comorbid condition." Jornal de Pediatria (Versão em Português) 96, no. 3 (May 2020): 276–78. http://dx.doi.org/10.1016/j.jpedp.2019.05.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Roth, Thomas. "Conclusion: Challenges in the comorbid condition." Sleep Medicine 8 (December 2007): S35. http://dx.doi.org/10.1016/s1389-9457(08)70007-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Baweja, Raman, and Debra Byler. "Tourette’s Syndrome and Comorbid Neurological Condition." Current Developmental Disorders Reports 4, no. 3 (June 9, 2017): 61–63. http://dx.doi.org/10.1007/s40474-017-0113-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

KALOGIROU, D., G. ANTONIOU, P. KARAKITSOS, O. KALOGIROU, D. ANTONIOU, and G. PROESTAKIS. "Radical Hysterectomy: Is Obesity a Comorbid Condition?" Journal of Gynecologic Surgery 13, no. 1 (January 1997): 7–12. http://dx.doi.org/10.1089/gyn.1997.13.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Vinodhini, Palaniappan, Syeda Aisha, and Chambayil Susheel Swathi. "Central Auditory Processing Disorder: A Comorbid Condition." Otolaryngology – Open Journal SE, no. 1 (April 18, 2019): S5—S9. http://dx.doi.org/10.17140/otloj-se-1-102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Swenor, B., B. Munoz, and S. West. "IS VISUAL IMPAIRMENT JUST ANOTHER COMORBID CONDITION?" Innovation in Aging 1, suppl_1 (June 30, 2017): 180. http://dx.doi.org/10.1093/geroni/igx004.693.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Nair, Uma S., Melanie L. Bell, Nicole P. Yuan, Betsy C. Wertheim, and Cynthia A. Thomson. "Associations Between Comorbid Health Conditions and Quit Outcomes Among Smokers Enrolled in a State Quitline, Arizona, 2011-2016." Public Health Reports 133, no. 2 (March 2018): 200–206. http://dx.doi.org/10.1177/0033354918764903.

Full text

Abstract:

Objective: Smokers with comorbid health conditions have a disproportionate burden of tobacco-related death and disease. A better understanding of differences in quit rates among smokers with comorbid health conditions can guide tailoring of quitline services for subgroups. The objective of this study was to examine self-reported tobacco cessation rates among Arizona Smokers’ Helpline callers with chronic health conditions (CHCs) and/or a mental health condition (MHC). Methods: We analyzed data from quitline telephone callers (n = 39 779) who enrolled in and completed at least 1 behavioral counseling session (ie, coaching call). We categorized callers as CHC only (cardiovascular disease/respiratory-related/cancer; 32%), MHC only (eg, mood/anxiety/substance dependence; 13%), CHC + MHC (25%), or no comorbid condition (30%). We assessed 30-day abstinence at 7-month follow-up for 16 683 clients (41.9%). We used logistic regression analysis to test associations between comorbidity and quit outcomes after controlling for relevant variables (eg, nicotine dependence). Results: Overall quit rates were 45.4% for those with no comorbid condition, 43.3% for those with a CHC only, 37.0% for those with an MHC only, and 33.3% for those with CHC + MHC. Compared with other groups, the CHC + MHC group had the lowest odds of quitting (adjusted odds ratio = 0.60; 95% confidence interval, 0.52-0.69). Conclusion: Having a comorbid condition was associated with lower quit rates, and smokers with co-occurring CHCs and MHCs had the lowest quit rates. Quitlines should evaluate more intensive, evidence-driven, tailored services for smoking cessation among callers with comorbid conditions.

APA, Harvard, Vancouver, ISO, and other styles

10

Ahmad Liaquat, Rabia Naseer, Tahmasub Faraz Tayyab, Muhammad Rashid, Komal Qudsia Sattar, and Javeria Usman. "Frequency of medical comorbidities in patients attending ORM & Maxillofacial Surgery Department at University College of Dentitistry, University of Lahore." Professional Medical Journal 29, no. 03 (February 28, 2022): 377–81. http://dx.doi.org/10.29309/tpmj/2022.29.03.6621.

Full text

Abstract:

Objectives: To find the frequency and type of comorbid conditions in patients presenting with oral diseases. Study Design: Observational study. Setting: Department of Oral and Maxillofacial Surgery, University College of Dentistry, University of Lahore. Period: January 2018 to December 2019. Material & Methods: After approval from the ethical committee, all cases presenting with oral diseases to the oral and maxillofacial surgery department were recruited consecutively. A thorough history and relevant examinations were made. All the previous records of the patient, including laboratory tests and the medical summary, were reviewed for the existence of any comorbid conditions. The data was entered on the spreadsheet. Descriptive statistics were used. Frequencies and percentages were calculated for comorbid conditions. Results: This study included 17155 patients who visited the oral and maxillofacial surgery department for procedures related to oral surgery. Others patients presenting to other departments of dentistry were excluded. Out of these, 4056 patients (24%) had comorbid conditions. Among these patients, 77% had single comorbid condition and 23% had multiple systemic disease. The most common comorbid condition was hypertension (77%), followed by diabetes (33%) and hepatitis (11%). Conclusion: A high prevalence of comorbidities was found in our study. Hypertension, diabetes mellitus, and hepatitis C were the common comorbidities. In addition, a significant number of patients had multiple comorbidities.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Comorbid condition"

1

Averyt, Jennifer C. "An Examination of Comorbid Pain Conditions in Type 2 Diabetes." Ohio University / OhioLINK, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1344018859.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Shivalikanjli, Anu. "Genetics and epigenetics of attention-deficit/hyperactivity disorder and comorbid conditions." Doctoral thesis, Universitat de Barcelona, 2021. http://hdl.handle.net/10803/673465.

Full text

Abstract:

The broad objectives of this work are the identification of genes that contribute to the susceptibility to attention-deficit/hyperactivity disorder (ADHD) and cocaine dependence, two disorders that co-occur in patients. In this Thesis, we describe (i) the contribution to ADHD of allele-specific methylation (ASM), an epigenetic mechanism that involves single single- nucleotide polymorphisms (SNPs) correlating with differential levels of DNA methylation at CpG sites, (ii) the role of microRNA (miRNA) genes in ADHD, and (iii) a genome-wide association meta-analysis of cocaine dependence. We also explore the common genetic basis that explains the comorbidity between these disorders. The main results from the three studies include: (i) Common genetic risk variants for ADHD identified in a previous genome-wide association study (GWAS) that included 20,000 cases and 35,000 controls are enriched in SNPs that correlate with levels of DNA methylation. Eight ASM SNPs were found significantly associated with ADHD and correlated with differential methylation at six CpG sites in cis in different brain areas. These six CpG sites are located at possible promoter regions of six genes expressed in brain: ARTN, C2orf82, NEUROD6, PIDD1, RPLP2 and GAL. Based on the bioinformatic functional analyses of these genes, our study highlights the candidacy of ARTN, C2orf82 and PIDD1 genes as potential contributors to ADHD susceptibility. (ii) We conducted a case-control association study to investigate the contribution to ADHD of common genetic variation in 1,761 autosomal miRNAs using pre-existing GWAS data from 20,000 cases and 35,000 controls. We identified significant associations of SNPs with ADHD that highlight 12 miRNA genes, all located within protein-coding genes. The associated variants are located in the putative regulatory regions of the miRNA genes or in the promoter region of the host protein-coding gene. We inspected the target genes, brain expression, homologs for the miRNAs and we propose miR-7-1 and miR-3666 as promising candidates since both are brain expressed, have validated brain-expressed targets, and homologs in model species. Pathway analysis of ADHD-associated miRNAs revealed miRNA-mediated regulation of serotonin receptor genes, well-known contributors to neurological functions and diseases. (iii) We performed the largest cocaine dependence GWAS meta-analysis in individuals of European ancestry, including 2,100 cases and 4,300 controls. Although SNP-based analysis revealed no genome-wide significant associations with cocaine dependence, probably due to limited sample size, gene-based analysis identified the HIST1H2BD gene, previously associated with schizophrenia. The estimated SNP-based heritability of cocaine dependence was estimated as 30%. A significant genetic correlation was found between cocaine dependence and ADHD, schizophrenia, major depressive disorder and risk-taking behaviour, suggesting a shared genetic basis across pathologies and traits. Polygenic risk score (PRS) analysis shows that all the comorbid features analysed (ADHD, schizophrenia, major depressive disorder, aggressiveness, antisocial personality or risk-taking behaviour) can predict cocaine dependence. Overall, we identified common genetic and epigenetic risk factors that underlie the susceptibility to ADHD and to cocaine dependence. The results reinforce the idea that epigenetic mechanisms dictate the differential expression of genes that may be causal to ADHD. Cocaine dependence, which has been widely believed to occur under environmental and epigenetic influences, is also in part genetically determined. Finally, ADHD and cocaine dependence are comorbid disorders, and the observed genetic correlation between these conditions can reflect biological pleiotropy.
Aquest treball té com a objectiu principal la identificació de gens que contribueixen a la susceptibilitat al trastorn per dèficit d’atenció amb hiperactivitat (TDAH) i a la dependència de cocaïna, dos trastorns que es presenten amb freqüència conjuntament en pacients. En aquesta Tesi es descriu (i) la contribució al TDAH de la metilació específica de l’al·lel (ASM), un mecanisme epigenètic pel qual variants polimòrfiques presenten correlació amb nivells diferencials de metilació de l’ADN en llocs CpG, (ii) el paper dels gens de microRNAs (miRNAs) en el TDAH, i (iii) una meta-anàlisi d’estudis d’associació a escala genòmica de la dependència de cocaïna. També explorem la base genètica comuna que explica la comorbiditat entre aquests dos trastorns. Els principals resultats dels tres estudis són: (i) Les variants genètiques comunes de risc al TDAH identificades en un estudi previ d’associació a escala genòmica (GWAS) amb 20.000 casos i 35.000 controls estan enriquides en variants de canvi d’un sol nucleòtid (SNPs) que tenen influència sobre la metilació de l’ADN. Vuit SNPs de tipus ASM estan associats significativament amb el TDAH i presenten correlació amb la metilació diferencial de sis dinucleòtids CpG en cis en diferents àrees cerebrals. Aquests sis llocs CpG estan en possibles regions promotores de sis gens que s’expressen al cervell: ARTN, C2orf82, NEUROD6, PIDD1, RPLP2 i GAL. En base a anàlisis bioinformàtiques d’aquests gens a nivell funcional, el nostre estudi prioritza els gens ARTN, C2orf82 i PIDD1 com a possibles contribuents a la susceptibilitat al TDAH. (ii) Hem dut a terme un estudi d'associació cas-control per investigar la contribució al TDAH de la variació genètica comuna en 1.761 miRNA autosòmic s utilitzant dades GWAS preexistents de 20.000 casos i 35.000 controls. Hem identificat associacions significatives de SNPs amb el TDAH que assenyalen 12 gens de miRNAs, tots situats dins de gens que codifiquen proteïnes. Les variants associades estan situades en suposades regions reguladores dels gens de miRNA o a la regió promotora del gen hoste. Hem inspeccionat els gens diana dels miRNAs, la seva expressió en cervell i els gens homòlegs en altres espècies, i proposem els gens miR-7-1 i miR-3666 com a candidats prometedors, ja que tots dos són s’expressen al sistema nerviós central, tenen dianes validades que s’expressen també en cervell i tenen homòlegs en espècies model. L’anàlisi de vies a partir dels miRNAs associats al TDAH ha assenyalat gens de receptors de serotonina regulats pels nostres miRNAs, la relació dels quals amb funcions i malalties neurològiques és ben coneguda. (iii) Hem realitzat la metaanàlisi més gran fins ara de dades GWAS de dependència de cocaïna en individus d'ascendència europea, amb 2.100 casos i 4.300 controls. Tot i que l’anàlisi basada en SNPs no ha revelat cap associació significativa amb la dependència de cocaïna, probablement a causa de la mida mostral limitada, l’anàlisi basada en gens ha permès identificar el gen HIST1H2BD, anteriorment associat a l’esquizofrènia. Hem calculat també l'heretabilitat basada en SNPs de la dependència de cocaïna, que seria d’un 30%. Hem detectat una correlació genètica significativa entre la dependència de cocaïna i el TDAH, l’esquizofrènia, el trastorn depressiu major i els comportaments de risc, tot suggerint que hi ha una base genètica compartida entre patologies i trets. L’anàlisi de la puntuació de risc poligènic (PRS) mostra que totes les característiques comòrbides analitzades (TDAH, esquizofrènia, trastorn depressiu major, agressivitat, personalitat antisocial o comportament s de risc) prediuen la dependència de la cocaïna. En resum, hem identificat factors de risc genètics i epigenètics freqüents a la població que contribueixen a la susceptibilitat al TDAH i a la dependència de cocaïna. Els resultats reforcen la idea que els mecanismes epigenètics estan relacionats amb l'expressió diferencial de gens que poden contribuir al TDAH. La dependència de cocaïna, que fins ara s’havia relacionat amb factors de risc ambientals i epigenètics, també estaria determinada, en part, per factors genètics. Finalment, el TDAH i la dependència de la cocaïna són trastorns comòrbids i la correlació genètica observada entre aquestes afeccions pot reflectir pleiotropia biològica.

APA, Harvard, Vancouver, ISO, and other styles

3

Lee, Dong Hyung. "Testing executive function models of ADHD and its comorbid conditions: A latent variable approach." Diss., Texas A&M University, 2004. http://hdl.handle.net/1969.1/2801.

Full text

Abstract:

Current theoretical models of ADHD (i.e., Disinhibition Model: Barkley, 1997; Working Memory Model: Rapport et al., 2001) conceptualize ADHD as the disorder of executive function (EF) with some variation in their emphases on particular components of the broadly-defined EF (e.g., working memory vs. inhibition) and in their postulated relationships with ADHD symptoms. Although these models provide systematic accounts of the manifestation of ADHD, they have not been extensively tested from an empirical standpoint. Moreover, despite the fact that ADHD is highly comorbid with other additional conditions such as learning and behavioral problems and EF deficits are found in individuals with these conditions as well as in those with ADHD, current EF models have not specified the developmental relationship between ADHD and its comorbid conditions. This study was: (1) to examine the extent to which two current models of ADHD are supported in a sample of 102 adults; (2) to present an ??integrated?? model by combining two current models of ADHD and linking them to recent research findings on two common comorbid conditions with ADHD (i.e., reading difficulty and substance abuse); and (3) to test and revise such an integrated model in the light of data using a latent variable analysis. Major findings provided a strong support for the Working Memory Model with a lesser degree of support for the Disinhibition Model. Preliminary evidence of working memory as the primary deficit in ADHD was also obtained in the present sample. Finally, the integrated EF model and its revised model (final model) demonstrated a very good fit to the data. These findings suggest that the integrated model provides a unified account of how EF deficits contribute to the manifestation of ADHD symptoms and comorbid conditions with ADHD. Given some limitations (e.g., sample size and scope) of the present study, current findings need to be replicated.

APA, Harvard, Vancouver, ISO, and other styles

4

Booth, Josephine N. "Executive functions and children's reading difficulties : the effects of task modality, cognitive ability and comorbid conditions." Thesis, University of Strathclyde, 2011. http://oleg.lib.strath.ac.uk:80/R/?func=dbin-jump-full&object_id=15494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kalmus, Margot. "The prevalence of Comorbid conditions in a primary care sample of people with treatment resistant depression." Thesis, University of Essex, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.517411.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Vlotman, Carmen Ilse. "Common active comorbid medical conditions among mental health users treated by the assertive community treatment team at Valkenberg Psychiatric hospital." Master's thesis, Faculty of Health Sciences, 2018. http://hdl.handle.net/11427/30138.

Full text

Abstract:

Introduction People with severe mental illness have co-morbid medical conditions which are often undiagnosed and untreated leading to morbidity and mortality. Aims and Objectives The aim of this study was to investigate the documented rate of comorbid medical conditions in the Valkenberg Hospital Assertive Community Treatment (ACT) service population. The objectives were to determine the rate and type of comorbid medical conditions documented at the community clinic and to compare these findings with data recorded in the ACT services files. Analysis was undertaken to determine whether there was an association between the clinical measures and socio-demographic findings. Methods A descriptive, analytical, retrospective folder review was conducted on the ACT population of Valkenberg hospital. All clients treated by the ACT team between the 1st of January 2015 and the 31st of December 2015 were included in the study. The data was collected using a questionnaire. Results The ACT team treated 104 patients during the time of the study period. The age range was 21 to 63 years old (median 46). Thirty six of the patients were female (34.6%), sixty-eight (65.4%) were male. Substance use was documented in ninety-one (n=91) (87.5%) of all cases. Smoking was documented in sixty five (62.5%) of patients. Of the entire study sample, fifty-three patients (50.9%) had at least one medical condition. The most common active medical conditions documented at the patients’ combined treatment facilities were medication side-effects (22.3%), hypercholesterolemia (18.1%) and hypertension (10.6%). Significantly more medical conditions were recorded at Valkenberg hospital compared to the community clinics. There was an increase in metabolic illnesses in the middle age (44-53 years) group. Hypertension, diabetes mellitus and HIV appear to be slightly more common in females compared to males in this population. Discussion The study found comparatively low rates of medical conditions among the patients managed by the ACT team of Valkenberg hospital and the community clinics. These findings are not consistent with reviewed literature that found high rates of chronic medical conditions among people with severe mental illness. The rate of comorbid medical conditions is likely to be underestimated as they were not routinely screened for at both Valkenberg hospital and the community health centres. Conclusion The study highlights a gap between the management of mental illness and medical conditions in the ACT population. This has implication for the service provision of these clients in future.

APA, Harvard, Vancouver, ISO, and other styles

7

Sansing, William K. Jr. "A quantitative study of the relationships between activity limitation and participation restriction among older people with vision impairment and comorbid conditions." Thesis, Mississippi State University, 2015. http://pqdtopen.proquest.com/#viewpdf?dispub=3700055.

Full text

Abstract:

The purpose of the study was to investigate the prevalence and effects of vision impairment co-existing with other comorbid conditions. Utilizing the 2008 National Health Interview Survey, the most recent nationally representative data including expanded vision, health conditions, and activity questions, this study examined the effect of vision impairment co-existing with selected comorbid conditions among non-institutionalized older adults age ≥ 55 years. Specifically, this study compared 4 groups: (a) older adults with neither vison impairment nor comorbid conditions, (b) older adults with vision impairment only, (c) older adults with comorbid conditions only, and (d) older adults with both vision impairment and each of the comorbid conditions to examine the prevalence and effect of vision impairment and comorbid conditions on selected mobility and vision activity limitations, and participation restrictions. Using complex sample techniques to conduct frequency analyses and logistic regression procedures, this study compared these groups of older adults to document the likelihood of experiencing mobility and vision activity limitations, and participatory restrictions.

These results suggest that older adults reporting vision impairments are a heterogeneous population, overwhelmingly use corrective lenses, and experience substantial mobility and vision activity limitations, and participatory restrictions; however, relatively few report using low vision aids or rehabilitation services. In addition, these results revealed, even when controlling for age, sex, race/ethnicity, marital status, region of residence, and health status, older adults with vision impairment and any of the selected comorbid conditions were statistically significantly more likely to report mobility and vision activity limitations, and participation restrictions. Moreover, when comparing older adults reporting vision impairment co-existing with comorbid conditions older adults reporting either vision impairment only or a comorbid condition only, the results suggest vision impairment had the largest statistically significant effect on the likelihood of mobility or vision activity limitations, or participatory restriction in 29 of the 44 logistic regression analyses. These findings are significant as vision impairment is framed as a public health concern, and can inform improvements in programs and services for older adults. Finally, these findings highlight the need for expanded research examining the effect of specific eye diseases and comorbid conditions among older adults.

APA, Harvard, Vancouver, ISO, and other styles

8

Jones, B. F. "The impact of a lack of medical explanation for pain, 'medically unexplained' comorbid conditions, and ethnicity on CBT therapists' judgments of pain and treatment decisions." Thesis, University College London (University of London), 2016. http://discovery.ucl.ac.uk/1521056/.

Full text

Abstract:

This three-part thesis reviews the effectiveness of cognitive behavioural therapies for medically unexplained symptoms on healthcare use, investigates the impact of a lack of a medical explanation for pain, 'medically unexplained' comorbid conditions, and ethnicity on CBT therapists' judgments of pain and treatment decisions, and discusses the challenges that were faced in the conducting and reporting of this research. Part one of this volume is a review and meta-analysis of 16 randomised controlled trials of cognitive behavioural interventions for people with medically unexplained symptoms. Borderline significant effects were found for one analysis each of reduced healthcare contacts/resource use, as well as for medication use. There was no significant effect found for reduced medical investigations. Part two of this volume is an empirical study that investigates the impact of a lack of a medical explanation for pain, 'medically unexplained' comorbid conditions, and ethnicity on CBT therapists' judgments of pain and treatment decisions. Small, but significant effects were found for the impact of a lack of a medical explanation for pain and comorbid conditions on CBT therapists' estimations of pain severity and exaggeration. A large effect was found for the impact of comorbid conditions on estimations of pain being caused by a mental health problem. These factors were also found to have an impact on treatment decisions. No effect on pain judgments was found for the variable of ethnicity, but ethnicity was found to have an impact on treatment decisions. Part three is a critical appraisal of the literature review and research process as a whole. It contains some personal reflections on the different stages of research and the challenges that were faced.

APA, Harvard, Vancouver, ISO, and other styles

9

Eppelheimer, Maggie S. "Identification of Chiari Malformation Type I Brain Morphology and Biomechanics: A Multi-Faceted Approach to Determine Diagnostic and Treatment Criteria." University of Akron / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=akron1595680107882868.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Washburn, DUSTIN. "Theory of Mind Decoding and Reasoning Abilities in Depression, Social Phobia, and Comorbid Conditions." Thesis, 2012. http://hdl.handle.net/1974/7406.

Full text

Abstract:

Vulnerability to major depressive disorder (MDD) is characterized by extensive interpersonal dysfunction. A framework that has been used to understand this impairment is theory of mind, or the ability to decode and reason about others’ mental states. Previous research has identified a mental state decoding advantage in individuals with a past history of MDD, which has been explained in terms of an enhanced social orientation in those with depression vulnerability. Although social phobia is highly comorbid with MDD, there is no research investigating theory of mind abilities in individuals with social phobia, nor has there been research examining how social anxiety may better account for the relation of depression to heightened theory of mind ability. Furthermore, there is a paucity of research investigating whether evidence of such a relation extends to the more complex task of reasoning about others’ mental states. Thus, the goals of the current investigation were to examine whether heightened ToM accuracy in those with a history of MDD is better accounted for by social phobia, and whether superior ToM skills in those with past MDD are seen across tasks that tap the domains of decoding and reasoning. Participants (N = 109) were assigned to one of four groups based on a structured diagnostic interview: (a) past MDD only (n = 36); (b) social anxiety disorder only (n = 9); (c) comorbid past MDD and social anxiety disorder (n = 23); and (d) no psychiatric history (n = 41). Results show that having a history of MDD is associated with heightened mental state reasoning abilities only in the presence of current social phobia. However, theory of mind decoding was not elevated in this condition. This suggests that social phobia differentially influences the relation of past MDD and theory of mind ability for decoding and reasoning abilities. Furthermore, social phobia without a history of depression was associated with poor theory of mind decoding and reasoning. This reduced ability in individuals with social phobia may be the result of self-focused attention or avoidance of potential negative evaluation, but future research is required to specifically address these possibilities.
Thesis (Master, Psychology) -- Queen's University, 2012-08-28 10:30:44.686

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Comorbid condition"

1

Y, Hwang Michael, and Bermanzohn Paul C, eds. Schizophrenia and comorbid conditions: Diagnosis and treatment. Washington, DC: American Psychiatric Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Matson, Johnny L., and Michael L. Matson, eds. Comorbid Conditions in Individuals with Intellectual Disabilities. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-15437-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Matson, Johnny L., ed. Comorbid Conditions Among Children with Autism Spectrum Disorders. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-19183-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Walter, Menninger W., and American Psychiatric Association. (147th : 1994 : Philadelphia, Pa.), eds. Fear of humiliation: Integrated treatment of social phobia and comorbid conditions. Northvale, N.J: Jason Aronson, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

O'Hara, Michael W., and C. Steven Richards. Epilogue. Edited by C. Steven Richards and Michael W. O'Hara. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199797004.013.037.

Full text

Abstract:

The authors of the chapters in this volume have covered nearly every feature of depression comorbidity with other psychiatric disorders, chronic health conditions, and disturbed close relationships. Treatment implications are addressed both in chapters on individual disorders as well as comprehensively in separate chapters. This volume concludes with the “big picture” provided by Ronald Kessler and his colleagues. Several themes emerge. Depression comorbidity is pervasive. It touches to one degree or another almost every identifiable psychiatric condition, chronic health condition, and disturbed close relationship. There are numerous potential explanations for this pervasive comorbidity that depend in part on the comorbid disorder. Depression comorbidity is associated with greater disease burden, resistance to treatment, increased primary disease morbidity, and mortality relative to cases in which comorbid depression is not present. Although depression comorbidity is common across psychiatric disorders, it is especially common among the anxiety disorders, raising questions as whether these disorders are really distinct. The assessment and treatment of comorbid disorders is complicated and often requires interdisciplinary collaboration. Although great strides have been made in the study of depression comorbidity, there is much left to be learned, so that we will be able to provide the most effective possible care to our patients who suffer from comorbid depression.

APA, Harvard, Vancouver, ISO, and other styles

6

Haegerich, Tamara M., and Patrick H. Tolan. Delinquency and Comorbid Conditions. Oxford University Press, 2011. http://dx.doi.org/10.1093/oxfordhb/9780195385106.013.0006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Matson, Michael L., and Johnny L. Matson. Comorbid Conditions in Individuals with Intellectual Disabilities. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Matson, Michael L., and Johnny L. Matson. Comorbid Conditions in Individuals with Intellectual Disabilities. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Matson, Michael L., and Johnny L. Matson. Comorbid Conditions in Individuals with Intellectual Disabilities. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Matson, Michael L., and Johnny L. Matson. Comorbid Conditions in Individuals with Intellectual Disabilities. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Comorbid condition"

1

Kirchen, Gwynne, and Meredith C. B. Adams. "Case 15: Comorbid Psychological Condition." In Hospitalized Chronic Pain Patient, 139–41. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-08376-1_25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lin, Di, and Fabrice Labeau. "Monitoring Patients in a Comorbid Condition with the Aid of Computerized Decision Support System." In Concepts and Trends in Healthcare Information Systems, 79–101. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-06844-2_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Messerli, Franz H. "Comorbid conditions." In Clinician’s Manual: Treatment of Hypertension, 55–66. Tarporley: Springer Healthcare Ltd., 2011. http://dx.doi.org/10.1007/978-1-907673-32-0_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Durand, V. Mark. "Comorbid conditions." In Autism spectrum disorder: A clinical guide for general practitioners., 57–65. Washington: American Psychological Association, 2014. http://dx.doi.org/10.1037/14283-003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Wein, Alan J., and Christopher Chapple. "Comorbid Conditions and Complications." In Overactive Bladder in Clinical Practice, 143–47. London: Springer London, 2011. http://dx.doi.org/10.1007/978-1-84628-831-9_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Caudell, Gage M., and Mindi Feilmeier. "Complications Associated with Comorbid Conditions." In Complications in Foot and Ankle Surgery, 89–95. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-53686-6_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Toby, Lauryn M. "Common Comorbid Conditions with Autism." In A Spectrum of Solutions for Clients with Autism, 221–27. New York, NY : Routledge, 2020.: Routledge, 2020. http://dx.doi.org/10.4324/9780429299391-29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Thertus, Ketty. "Pharmacotherapy for Treatment of Comorbid Conditions." In Pain, 393–96. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99124-5_87.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kohutek, Z. A., and B. A. Murphy. "Supportive Care, Comorbid Conditions, and Survivorship." In Multidisciplinary Management of Head and Neck Cancer, 187–97. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-05973-5_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Adams, Hilary L., and Johnny L. Matson. "Scope and Prevalence of the Problem." In Comorbid Conditions in Individuals with Intellectual Disabilities, 3–24. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-15437-4_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Comorbid condition"

1

Lin, Di, Fabrice Labeau, and Subhra Mohapatra. "Decision Support System for Constantly Monitoring Patients in a Comorbid Condition." In 2013 IEEE International Conference on Healthcare Informatics (ICHI). IEEE, 2013. http://dx.doi.org/10.1109/ichi.2013.46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lin, Di, Fabrice Labeau, and GuiXia Kang. "Decision support system for monitoring hypertensive patients in a comorbid condition." In 2013 IEEE Conference on Prognostics and Health Management (PHM). IEEE, 2013. http://dx.doi.org/10.1109/icphm.2013.6621429.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hohmann, S. "The Impact of Bronchiectasis as a Comorbid Condition on Outcomes of Hospitalization." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5701.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Garneau-Picard, F. A., M. E. Boulay, and L. P. Boulet. "Gender Differences in Asthma-COPD Overlap and Associated Comorbid Conditions." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1471.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Davis, Claudia M., and Hector F. Myers. "Abstract A58: Comorbid conditions among African American breast cancer survivors." In Abstracts: Seventh AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 9-12, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7755.disp14-a58.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Tejedor, Richard, and Nereida Parada. "Asthma Disease Management: Appropriate For Patients With Comorbid Medical Conditions?" In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2598.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Nagpal, Chirag, Kyle Miller, Tiffany Pellathy, Marilyn Hravnak, Gilles Clermont, Michael Pinsky, and Artur Dubrawski. "Semi-Supervised Prediction of Comorbid Rare Conditions Using Medical Claims Data." In 2017 IEEE International Conference on Data Mining Workshops (ICDMW). IEEE, 2017. http://dx.doi.org/10.1109/icdmw.2017.68.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Uzaslan, Esra, Ozge A. Guclu, Nilufer A. A. Ozturk, Asli Dilektasli, Ezgi D. Cetinoglu, and Mehmet Karadag. "Comorbid conditions and social determinants of smoking in the adult population." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa1261.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gonçalves, Ivone M., Filipa Viveiros, and Aurora Carvalho. "Prevalence And Influence Of Comorbid Conditions, Age And Gender On Asthma." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Koc, Aysu Sinem, Nesrin Mogulkoc, and Paul Bishop. "Comorbid conditions in IPF patients; their frequencies and impacts on survival." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2915.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Comorbid condition"

1

Tangka, Florence K. L., Sujha Subramanian, Madeleine Jones, Patrick Edwards, Sonja Hoover, Tim Flanigan, Jenya Kaganova, et al. Young Breast Cancer Survivors: Employment Experience and Financial Well-Being. RTI Press, July 2020. http://dx.doi.org/10.3768/rtipress.2020.rr.0041.2007.

Full text

Abstract:

The economic burden of breast cancer for women under 50 in the United States remains largely unexplored, in part because young women make up a small proportion of breast cancer cases overall. To address this knowledge gap, we conducted a web-based survey to compare data from breast cancer survivors 18–39 years of age at first diagnosis and 40–49 years of age at first diagnosis. We administered a survey to a national convenience sample of 416 women who were 18–49 years of age at the time of their breast cancer diagnosis. We analyzed factors associated with financial decline using multivariate regression. Survivors 18–39 years of age at first diagnosis were more likely to report Stage II–IV breast cancer (P<0.01). They also quit their jobs more often (14.6%) than older survivors (4.4%; P<0.01) and faced more job performance issues (55.7% and 42.8%, respectively; P=0.02). For respondents in both groups, financial decline was more likely if the survivor had at least one comorbid condition (odds ratios: 2.36–3.21) or was diagnosed at Stage II–IV breast cancer (odds ratios: 2.04–3.51).

APA, Harvard, Vancouver, ISO, and other styles

2

Miller, Kaleigh. US Guided Management of Undifferentiated Dyspneic Patient in the ED. University of Tennessee Health Science Center, March 2020. http://dx.doi.org/10.21007/com.lsp.2020.0001.

Full text

Abstract:

Intro: Undifferentiated dyspnea can be a complicated presentation muddled by patient comorbidities and similar symptomology shared among etiologies. Some studies have shown increased mortality and length of stay in the hospital when incorrectly initially diagnosed in the ED. US has been shown more effective at differentiating these causes and improves diagnostic accuracy. This study will implement US exam upon initial exam of patient and chart time to diagnosis/treatment, length of stay in ED, length of stay in hospital admissions versus discharge rates, and 30 day mortality. ADHF and COPD/asthma patient differentiation will be the focus. Methods: Prospective cohort study of more than 18 years that present with the primary complaint of dyspnea with more than one complicating comorbid condition. Initial exam by physician will be accompanied by cardiothoracic US previously verified. Results: Study powered by previous year average of time to diagnosis of institution. Patient characteristics, distribution by diagnostic category, and characteristics found on US in correlation with diagnosis will be included for multivariate analysis. Conclusions: We expect to see a singificant difference in our time to diagnosis/treatment and mortality rate.

APA, Harvard, Vancouver, ISO, and other styles

3

Nylund, Cade, Gregory H. Gorman, Matthew D. Eberly, Elizabeth Hisle-Gorman, Anthony Goudie, Adam Huillet, Matilda Eide, Stephen L. Nelson, Christine Erdie-Lalena, and Luis E. Lozada. Risk Factors, Comorbid Conditions, and Epidemiology of Autism in Children. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada613604.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Madu, Laura, Jacqueline Sharp, and Bobby Bellflower. Efficacy of Integrating CBT for Mental Health Care into Substance Abuse Treatment in Patients with Comorbid Disorders of Substance Abuse and Mental Illness. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/con.dnp.2021.0004.

Full text

Abstract:

Abstract: Multiple studies have found that psychiatric disorders, like mood disorders and substance use disorders, are highly comorbid among adults with either disorder. Integrated treatment refers to the treatment of two or more conditions and the use of multiple therapies such as the combination of psychotherapy and pharmacotherapy. Integrated therapy for comorbidity per numerous studies has consistently been superior to the treatment of individual disorders separately. The purpose of this QI project was to identify the effectiveness of Cognitive Behavioral Therapy (CBT) instead of current treatment as usual for treating Substance Use Disorder (SUD) or mental health diagnosis independently. It is a retrospective chart review. The review examines CBT's efficacy for engaging individuals with co-occurring mood and substance u se disorders in treatment by enhancing adherence and preventing disengagement and relapse. Methods: Forty adults aged 26-55 with a DSM-IV diagnosis of a mood disorder of Major Depressive Disorder and/or anxiety and concurrent substance use disorder (at least weekly use in the past month). Participants received 12 sessions of individual integrated CBT treatment delivered with case management over a 12-week period. Results: The intervention was associated with significant improvements in mood disorder, substance use, and coping skills at 4, 8, and 12 weeks post-treatment. Conclusions: These results provide some evidence for the effectiveness of the integrated CBT intervention in individuals with co-occurring disorders. Of note, all psychotherapies are efficacious; however, it would be more advantageous to develop a standardized CBT that identifies variables that facilitate treatment outcomes specifically to comorbid disorders of substance use and mood disorders. It is concluded that there is potentially more to be gained from further studies using randomized controlled designs to determine its efficacy.

APA, Harvard, Vancouver, ISO, and other styles

5

Schnabel, Filipina, and Danielle Aldridge. Effectiveness of EHR-Depression Screening Among Adult Diabetics in an Urban Primary Care Clinic. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/con.dnp.2021.0003.

Full text

Abstract:

Background Diabetes mellitus (DM) and depression are important comorbid conditions that can lead to more serious health outcomes. The American Diabetes Association (ADA) supports routine screening for depression as part of standard diabetes management. The PHQ2 and PHQ9 questionnaires are good diagnostic screening tools used for major depressive disorders in Type 2 diabetes mellitus (DM2). This quality improvement study aims to compare the rate of depression screening, treatment, and referral to behavioral health in adult patients with DM2 pre and post-integration of depression screening tools into the electronic health record (EHR). Methods We conducted a retrospective chart review on patients aged 18 years and above with a diagnosis of DM2 and no initial diagnosis of depression or other mental illnesses. Chart reviews included those from 2018 or prior for before integration data and 2020 to present for after integration. Sixty subjects were randomly selected from a pool of 33,695 patients in the clinic with DM2 from the year 2013-2021. Thirty of the patients were prior to the integration of depression screening tools PHQ2 and PHQ9 into the EHR, while the other half were post-integration. The study population ranged from 18-83 years old. Results All subjects (100%) were screened using PHQ2 before integration and after integration. Twenty percent of patients screened had a positive PHQ2 among subjects before integration, while 10% had a positive PHQ2 after integration. Twenty percent of patients were screened with a PHQ9 pre-integration which accounted for 100% of those subjects with a positive PHQ2. However, of the 10% of patients with a positive PHQ2 post-integration, only 6.7 % of subjects were screened, which means not all patients with a positive PHQ2 were adequately screened post-integration. Interestingly, 10% of patients were treated with antidepressants before integration, while none were treated with medications in the post-integration group. There were no referrals made to the behavior team in either group. Conclusion There is no difference between the prevalence of depression screening before or after integration of depression screening tools in the EHR. The study noted that there is a decrease in the treatment using antidepressants after integration. However, other undetermined conditions could have influenced this. Furthermore, not all patients with positive PHQ2 in the after-integration group were screened with PHQ9. The authors are unsure if the integration of the depression screens influenced this change. In both groups, there is no difference between referrals to the behavior team. Implications to Nursing Practice This quality improvement study shows that providers are good at screening their DM2 patients for depression whether the screening tools were incorporated in the EHR or not. However, future studies regarding providers, support staff, and patient convenience relating to accessibility and availability of the tool should be made. Additional issues to consider are documentation reliability, hours of work to scan documents in the chart, risk of documentation getting lost, and the use of paper that requires shredding to comply with privacy.

APA, Harvard, Vancouver, ISO, and other styles

6

Open Science, Rapid Publication, and Collaboration. ACAMH, January 2022. http://dx.doi.org/10.13056/acamh.18841.

Full text

Abstract:

JCPP Advances is already causing waves in the research sector with 38 papers published, and 4 papers having found policy mentions making a difference in the real world. In this podcast, we hear from Dr. Catharina Hartman about our Open Access journal, JCPP Advances, as well as her recent work with the CoCA (Comorbid Conditions of ADHD) project.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!